Results 141 to 150 of about 1,515,008 (404)

A Role of the Bile Salt Receptor FXR in Atherosclerosis

open access: yes, 2010
This study reviews current insights into the role of bile salts and bile salt receptors on the progression and regression of atherosclerosis. Bile salts have emerged as important modifiers of lipid and energy metabolism.
Albert K. Groen   +12 more
core   +1 more source

Possibilities of using rosuvastatin to achieve target level of low-density lipoprotein cholesterol in clinical practice

open access: yes, 2020
Statins are the cornerstone of therapy for hypercholesterolemia and coronary artery disease. A large number of studies have demonstrated the effectiveness of lipid-lowering therapy in preventing the progression of atherosclerosis and the development of ...
Igor V. Sergienko, Yuliia A. Prus
core   +1 more source

Hyperlipidemia Aggravates Alveolar Bone Loss via Periodontal Ligament Stem Cell Ferroptosis Through GSK3β Dependent Ubiquitin‐Mediated NRF2 Degradation

open access: yesAdvanced Science, EarlyView.
Lipid metabolic stress triggers ferroptosis in PDLSCs through the GSK3β/NRF2 pathway, thereby aggravating periodontal bone loss. Upregulated GSK3β promotes NRF2 ubiquitination and proteasomal degradation via β‐TrCP, suppressing NRF2 nuclear translocation and antioxidant target expression.
Yuxiao Zhang   +11 more
wiley   +1 more source

Decoding the Mechanism of Action of a Parasite TGFβ Antagonist Inspires the Creation of Cell‐Type‐Specific TGFβ Modulators

open access: yesAdvanced Science, EarlyView.
The mammalian TGFβ interacts with ubiquitously expressed TGFBR1 and TGFBR2, and current TGFβ‐targeting agents are non‐cell‐selective. The cooperative interaction of the modular parasite TGFβ antagonist with multiple host (co‐)receptors empowers the design of TGM chimeras and bispecific antibodies that activate or inhibit TGFβ signaling in a cell ...
Maarten van Dinther   +13 more
wiley   +1 more source

The effects of non-nutritive sweeteners on lipid profile in adults: a systematic review and meta-analysis of randomized controlled clinical trials

open access: yesScientific Reports
Non-nutritive sweeteners (NNS) have been suggested as a viable solution to reduce sugar consumption. However, conflicting and uncertain evidence regarding their impact on lipid profile exists. This meta-analysis assesses the effects of different types of
AmirHossein Najafi   +4 more
doaj   +1 more source

Lowering low-density lipoprotein cholesterol levels in patients with type 2 diabetes mellitus

open access: yes, 2014
Harold E Bays Louisville Metabolic and Atherosclerosis Research Center, Louisville, KY, USA Abstract: Type 2 diabetes mellitus (T2DM) is characterized by hyperglycemia, insulin resistance, and/or progressive loss of β-cell function.
Bays HE
core  

Intestinal Source Control of Lipid Metabolism by Enzyme‐Probiotic Encapsulated, Spatiotemporal Crosslinked, and Small Intestine‐Adhesive Hydrogel Microspheres

open access: yesAdvanced Science, EarlyView.
A thiol‐modified alginate hydrogel microsphere‐encapsulated enzyme‐probiotic biohybrid (AKK‐COD) system has been developed to address the spatiotemporal delivery and colonization challenges of small intestine‐targeted probiotic for lipid metabolism regulation. The system exerts sequential functions of intragastric protection, small intestinal adhesion,
Xiaolin Wu   +10 more
wiley   +1 more source

Oxidized Low-density Lipoprotein and Atherosclerosis

open access: yesJournal of Preventive, Diagnostic and Treatment Strategies in Medicine
Atherosclerosis is a chronic inflammatory disease characterized by lipid buildup and immune response dysregulation in the artery walls. One of the important participants is oxidized low-density lipoprotein (OxLDL), which is involved in both the ...
Ali M. A. Al-Kufaishi   +1 more
doaj   +1 more source

Caveolae and caveolin-1 mediate endocytosis and transcytosis of oxidized low density lipoprotein in endothelial cells [PDF]

open access: bronze, 2010
Shaowei Sun   +7 more
openalex   +1 more source

Quantification of apolipoprotein E receptors in human brain-derived cell lines by real-time polymerase chain reaction

open access: yes, 2004
Apolipoprotein (apo) E4 is a risk factor for Alzheimer's disease (AD) and other neurodegenerative diseases, compared to wild-type apoE3. The mechanism(s) is unknown.
Owen, JS   +7 more
core   +1 more source

Home - About - Disclaimer - Privacy